Identification |
Name: | 2-Oxazolidinone,5-(4-morpholinylmethyl)-3-[[(5-nitro-2-furanyl)methylene]amino]-, hydrochloride(1:1), (5S)- |
Synonyms: | 2-Oxazolidinone,5-(4-morpholinylmethyl)-3-[[(5-nitro-2-furanyl)methylene]amino]-,monohydrochloride, (5S)- (9CI); 2-Oxazolidinone,5-(4-morpholinylmethyl)-3-[[(5-nitro-2-furanyl)methylene]amino]-,monohydrochloride, (S)-; 2-Oxazolidinone,5-(morpholinomethyl)-3-[(5-nitrofurfurylidene)amino]-, monohydrochloride,(S)-(-)- (8CI);l-5-Morpholinomethyl-3-[(5-nitrofurfurylidene)amino]-2-oxazolidinonehydrochloride |
CAS: | 3031-51-4 |
Molecular Formula: | C13H16 N4 O6 . Cl H |
Molecular Weight: | 360.79 |
InChI: | InChI=1/C13H16N4O6.ClH/c18-13-16(14-7-10-1-2-12(22-10)17(19)20)9-11(23-13)8-15-3-5-21-6-4-15;/h1-2,7,11H,3-6,8-9H2;1H/b14-7+;/t11-;/m0./s1 |
Molecular Structure: |
|
Properties |
Flash Point: | 232.8°C |
Boiling Point: | 461.4°Cat760mmHg |
Density: | 1.58g/cm3 |
Specification: |
2-Oxazolidinone, 5-(morpholinomethyl)-3-((5-nitrofurfurylidene)amino)-, L-, monohydrochloride , its cas register number is 3031-51-4. It also can be called NF-260 ; levo-5-(Morpholinomethyl)-3-((5-nitrofurfurylidene)amino)-2-oxazolidinone hydrochloride ; 2-Oxazolidinone, 5-(morpholinomethyl)-3-((5-nitrofurfurylidene)amino)-, L-, monohydrochloride .
|
Report: |
IARC Cancer Review: Group 2B IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 7 (1987),p. 56.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Limited Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 7 (1974),p. 161.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) .
|
Flash Point: | 232.8°C |
Safety Data |
|
|